Kyung Ju Ryu

机构：Samsung (South Korea), Sungkyunkwan University · ORCID：0000-0003-0986-1475

发表论文 42 篇 · 总被引 878 次 · h-index 17

代表论文

• Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study (2020 · Blood · 被引 132)
• Isolation of Small Extracellular Vesicles From Human Serum Using a Combination of Ultracentrifugation With Polymer-Based Precipitation (2019 · Annals of Laboratory Medicine · 被引 70)
• Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma (2020 · BMC Cancer · 被引 38)
• Exosomal miR-1305 in the oncogenic activity of hypoxic multiple myeloma cells: a biomarker for predicting prognosis (2021 · Journal of Cancer · 被引 34)
• The influence of microbial dysbiosis on immunochemotherapy-related efficacy and safety in diffuse large B-cell lymphoma (2023 · Blood · 被引 29)
• Circulating Tumor DNA–Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas (2022 · Cancer Research and Treatment · 被引 21)